Could a common antipsychotic drug curb opioid cravings in cancer patients?
NCT ID NCT06200181
First seen Feb 17, 2026 · Last updated Jun 15, 2026 · Updated 16 times
Summary
This study tests whether olanzapine, a medication typically used for mental health conditions, can help lower opioid cravings and misuse in adults with cancer who are on long-term opioid therapy for pain. About 87 participants will receive either olanzapine or a placebo to see if the drug reduces craving and improves safety. The goal is to find a way to ease opioid-related risks while managing cancer pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MISUSE, OPIOID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.